Latest Erythropoiesis-stimulating agents Stories
-- Data presented at the National Kidney Foundation (NKF) Spring Meeting; single and multiple-dose pharmacokinetic and pharmacodynamic (PK/PD) studies support biosimilar application for Epoetin Hospira
PORTLAND, Oregon, March 12, 2015 /PRNewswire/ -- Erythropoietin is a glycoprotein hormone synthesized in the bone marrow that controls and regulates the mechanism of erythropoiesis
PORTLAND, Oregon, January 15, 2015 /PRNewswire/ -- A new report by Allied Market Research titled, "Global Erythropoietin (EPO) Drugs Market (Type, Application and Geography)
LAKE FOREST, Ill., Jan.
RARITAN, N.J. and SAN ANTONIO, Dec.
Phosphate Binder Combination Use in Dialysis is Low, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept.
AllMed webinar provides in-depth review of the latest standard of care for the use of ESAs in the treatment of Chronic Kidney Disease. Portland, OR (PRWEB) August
THOUSAND OAKS, Calif., Aug.
In patients with a traumatic brain injury (TBI), neither the administration of the hormone erythropoietin (EPO) or maintaining a higher hemoglobin concentration through blood transfusion resulted in improved neurological outcome at 6 months.